These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33246899)

  • 1. Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy.
    Metternich B; Wagner K; Geiger MJ; Hirsch M; Schulze-Bonhage A; Klotz KA
    Epilepsy Behav; 2021 Jan; 114(Pt A):107558. PubMed ID: 33246899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.
    Martin RC; Gaston TE; Thompson M; Ampah SB; Cutter G; Bebin EM; Szaflarski JP
    Epilepsy Behav; 2019 Aug; 97():105-110. PubMed ID: 31220785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.
    Thompson MD; Martin RC; Grayson LP; Ampah SB; Cutter G; Szaflarski JP; Bebin EM
    Epilepsy Behav; 2020 Oct; 111():107299. PubMed ID: 32759071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
    Gaston TE; Szaflarski M; Hansen B; Bebin EM; Szaflarski JP;
    Epilepsy Behav; 2019 Jun; 95():10-17. PubMed ID: 31003195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
    Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
    Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia.
    Neubauer D; Perković Benedik M; Osredkar D
    Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center.
    Ferrera G; Ricci E; Vignoli A; Savini MN; Viganò I; Chiesa V; Caputo D; Zambrelli E; La Briola F; Turner K; Canevini MP
    Epilepsy Behav; 2023 Oct; 147():109409. PubMed ID: 37677907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
    Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
    Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies.
    Brett BA; Conroy M; Doshi H; Lowe MX; Kalcheff-Korn S; Jackson H
    BMC Neurol; 2024 Apr; 24(1):141. PubMed ID: 38671370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
    Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
    Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.
    Szaflarski JP; Bebin EM; Comi AM; Patel AD; Joshi C; Checketts D; Beal JC; Laux LC; De Boer LM; Wong MH; Lopez M; Devinsky O; Lyons PD; Zentil PP; Wechsler R;
    Epilepsia; 2018 Aug; 59(8):1540-1548. PubMed ID: 29998598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.
    Gaston TE; Ampah SB; Martina Bebin E; Grayson LP; Cutter GR; Hernando K; Szaflarski JP;
    Epilepsy Behav; 2021 Apr; 117():107862. PubMed ID: 33667843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol in treatment of refractory epileptic spasms: An open-label study.
    Herlopian A; Hess EJ; Barnett J; Geffrey AL; Pollack SF; Skirvin L; Bruno P; Sourbron J; Thiele EA
    Epilepsy Behav; 2020 May; 106():106988. PubMed ID: 32169600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
    Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.